ClinicalTrials.gg
Drug

Nitric Oxide clinical trials

Also written INOmax.

studies test it
141
open now
12
in phase 3
36
first study started
1995

How each study uses Nitric Oxide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Nitric Oxide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Dec 1999 · INOMAX · NDA 020845 (FDA, Drugs@FDA)
European Union
1 Aug 2001 · INOmax · EMEA/H/C/000337 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nitric Oxide
71
Inhaled Nitric Oxide
42
iNO
20
Inhaled Nitric Oxide (iNO)
7
Nitric Oxide Gas
5

Brand

INOmax
21
GeNOsyl
1

Development codes

NDA 20-845
1
IK-3001
1

Studies by the year they started

141 studies that test it; most in 2020 (10)

Studies that test Nitric Oxide, by start year
YearStudies
19951
19982
19991
20002
20013
20023
20031
20044
20057
20064
20072
20085
20097
20104
20116
20126
20135
20142
20155
20169
20178
20186
20197
202010
20215
20223
20239
20246
20253
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
9
Phase 1
25
Phase 2
73
Phase 3
36
Phase 4
7
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 43 · Other 98

Mallinckrodt (15) · Massachusetts General Hospital (9) · Bellerophon Pulse Technologies (6) · Tomsk National Research Medical Center of the Russian Academy of Sciences (5) · Sanotize Research and Development corp. (5) · Beyond Air Inc. (5) · Wake Forest University Health Sciences (4) · University of Alberta (4)

Often tested with

Tested in the same studies.

Oxygen (1) · Epoprostenol (1) · Nitroglycerin (1) · Methylene Blue (1) · Carbon Monoxide (1) · Helium (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test Nitric Oxide, phase 3 first.

Studies

Open first, then newest update. How each study uses Nitric Oxide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 141

See all 141 studies that test Nitric Oxide →

Given beside what is tested · 1 — Nitric Oxide is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Nitric Oxide

Codes

What other systems call Nitric Oxide · ClinicalTrials.gg INT007899

  • MeSH (NLM) D009569Nitric OxideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 31C4KY9ESHNITRIC OXIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 7442Confirmed FDA, Wikidata
  • Wikidata Q207843nitric oxideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C695Nitric OxideOne source FDA
  • DrugBank DB00435One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.